News
6d
GlobalData on MSNLupin partners SteinCares to commercialise biosimilar in LATAMLupin has signed a licence and supply agreement with SteinCares to commercialise its biosimilar ranibizumab in Latin American ...
Maybe we don't have to worry about that $1,000 sticker price, after all! New Nothing Phone 3 price rumors settle on $800.
Novartis introduces a financing scheme with Pine Labs for its cholesterol-lowering drug, Sybrava (inclisiran), in India, ...
15h
The Print on MSNBig pharma pivoting to more lucrative obesity segment, Indian drugmakers eye insulin marketThe size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...
Several Indian pharmaceutical companies are ushering in the next generation of their promoter families to take over the reins ...
When the pandemic hit, Amita Naik didn’t panic — she pivoted. From selling raw milk to launching her own dairy brand, this ...
AmbitionBox, India's No. 1 platform for company reviews and salary insights, has announced the ABECA 2025 - AmbitionBox ...
The other key winners are Big FM, HT - Fever FM, Radio City, Club FM, Dabur India, Ultratech Cement, The Muthoot Group and ...
Glenmark Pharmaceuticals seeks licensing deal for ISB 2001 drug candidate, plans growth with semaglutide in India.
PR Newswire CHICAGO, May 23, 2025 CHICAGO Generic Pharmaceuticals Market size is projected to be valued at USD 391.5 billion in 2023 and r ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results